Labcorp Q3 revenue beats on organic growth, operating efficiencies 

By Reuters News


Overview

  • Global lab services provider's Q3 revenue rose 6.9% yr/yr, beating analyst expectations

  • Adjusted EPS for Q3 rose 14.5% yr/yr

  • Company raised full-year 2026 revenue growth and adjusted EPS guidance


Outlook

  • Labcorp raises 2026 revenue growth outlook to 5.9%-6.7% and adj EPS to $18.30-$18.70

  • Company expects 2026 Biopharma Laboratory Services revenue growth of 7.4%-8.4%

  • Labcorp sees 2026 Diagnostics Laboratories revenue growth of 5.5%-6.2%


Result Drivers

  • ORGANIC GROWTH & OPERATING EFFICIENCIES - Co attributed higher adjusted operating income and margin to organic growth and operating efficiencies

  • ACQUISITIONS - Co said recent acquisitions are expected to contribute to adjusted EPS and long-term growth

  • SPECIALTY TESTING EXPANSION - Co launched new specialty tests and expanded access through acquisitions


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$3.81 bln

$3.76 bln (12 Analysts)

Q3 Adj EPS from Cont Ops

$4.78


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for Labcorp Holdings Inc. is $355.00, about 7.2% above its October 27 closing price of $331.17

  • The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 15 three months ago


Reuters Recommended Reads

  • Oct 27 - Healthcare data firm IQVIA Q3 revenue beats on strong bookings

  • Oct 27 - Centene Q3 revenue tops estimates on Medicare growth

  • Oct 27 - Ensign Group Q3 adjusted EPS beats estimates, revenue up on higher occupancy rates


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk